Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Painted Playgrounds: Aim 2: Assessments: Complete Statistical AnalysisIndependent statistical analysis of Painted Playgrounds: Aim 2: Assessments: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03885518).
- Paired Promotion of Colorectal Cancer and Social Determinants of Health Screening: Complete Statistical AnalysisIndependent statistical analysis of Paired Promotion of Colorectal Cancer and Social Determinants of Health Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PAIRSIndependent statistical analysis of Study of Aripiprazole to Treat Children and Adolescents With Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00619190).
- PAL-HFIndependent statistical analysis of Palliative Care in Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01589601).
- PALACEIndependent statistical analysis of Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PALACE-1Independent statistical analysis of Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PALACE4Independent statistical analysis of Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food: Complete Statistical AnalysisIndependent statistical analysis of Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3): Complete Statistical AnalysisIndependent statistical analysis of Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children: Complete Statistical AnalysisIndependent statistical analysis of Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PALLASComplete statistical analysis of the PALLAS phase 3 trial of dronedarone versus placebo in patients with permanent atrial fibrillation, including trial design, time-to-event endpoints, hazard ratios, confidence intervals, p-values, and statistical interpretation.
- PALLASIndependent statistical analysis of PALbociclib CoLlaborative Adjuvant Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02513394).
- Palliative Care Consultations in the Skilled Nursing Facility (SNF) Setting: Complete Statistical AnalysisIndependent statistical analysis of Palliative Care Consultations in the Skilled Nursing Facility (SNF) Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03958552).
- PALOMA-2Independent statistical analysis of PALOMA-2 (NCT01740427), a randomized phase 3 trial of palbociclib plus letrozole versus placebo plus letrozole in postmenopausal women with ER+/HER2- advanced breast cancer.
- PALOMA-4Independent statistical analysis of PALOMA-4, a randomized phase 3 trial comparing palbociclib plus letrozole with placebo plus letrozole in Asian postmenopausal women with ER+/HER2- advanced breast cancer.
- Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer: Complete Statistical AnalysisIndependent statistical analysis of Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients: Complete Statistical AnalysisIndependent statistical analysis of Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PALSIndependent statistical analysis of Physical Activity and Leisure-time Study (PALS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01342471).
- Palu-COVIDIndependent statistical analysis of Malaria as a Protection Factor Against Severe COVID-19 (Known as SARS-COV-2) in the Democratic Republic of Congo (Palu-COVID): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Pamidronate to Treat Osteogenesis Imperfecta in Children: Complete Statistical AnalysisIndependent statistical analysis of Pamidronate to Treat Osteogenesis Imperfecta in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00005901).
- PAMMIndependent statistical analysis of Physiological Augmentation of Mindfulness Meditation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02754557).
- PAMSIndependent statistical analysis of Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PANAMAIndependent statistical analysis of PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PANCAX-3Independent statistical analysis of Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pancreas Resection With and Without Drains: Complete Statistical AnalysisIndependent statistical analysis of Pancreas Resection With and Without Drains: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01441492).
- Pancreaticobiliary Reflux in Patients Without Cholelithiasis: Complete Statistical AnalysisIndependent statistical analysis of Pancreaticobiliary Reflux in Patients Without Cholelithiasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00890201).
- PanECTIndependent statistical analysis of Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention: Complete Statistical AnalysisIndependent statistical analysis of Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02588339).
- Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01105312).
- Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size…
- PANORAMA_3Independent statistical analysis of Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02654990).
- PANTHEONIndependent statistical analysis of A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction: primary endpoint results, effect estimate with confidence interval, sample-size…
- PANTHERIndependent statistical analysis of Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD): primary endpoint results, effect estimate…
- PANTHERIndependent statistical analysis of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML): primary…
- Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00835588).
- PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer: Complete Statistical AnalysisIndependent statistical analysis of PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00088413).
- PAPALIndependent statistical analysis of A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01667107).
- PAPIIndependent statistical analysis of Potency and Precision Investigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06240091).
- PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD): Complete Statistical AnalysisIndependent statistical analysis of PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Paracervical Block During Office Hysteroscopy: Complete Statistical AnalysisIndependent statistical analysis of Paracervical Block During Office Hysteroscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00811187).
- Paracervical Block for Pain Associated With Laminaria Insertion: Complete Statistical AnalysisIndependent statistical analysis of Paracervical Block for Pain Associated With Laminaria Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02454296).
- Paracervical Block Versus No Paracervical Block During IUD Insertion: Complete Statistical AnalysisIndependent statistical analysis of Paracervical Block Versus No Paracervical Block During IUD Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02904915).
- Paracetamol With Caffeine to Treat Episodic Tension Type Headache: Complete Statistical AnalysisIndependent statistical analysis of Paracetamol With Caffeine to Treat Episodic Tension Type Headache: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01755702).
- paradigm™5Independent statistical analysis of Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- paradigm™6Independent statistical analysis of Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PARADYSEIndependent statistical analysis of A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…